ArticleInflammatory bowel diseases2024

Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease.

Itaru Iwama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.